Larson Financial Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89K Buy
124
+56
+82% +$2.36K ﹤0.01% 2870
2026
Q1
$3.76K Buy
68
+30
+79% +$1.43K ﹤0.01% 2732
2025
Q4
$1.42K Hold
38
﹤0.01% 2854
2025
Q3
$1.54K Sell
38
-2
-5% -$66 ﹤0.01% 2799
2025
Q2
$1.02K Buy
+40
New +$872 ﹤0.01% 2646

Other funds holding PAHC

Larson Financial Group's PAHC Position: Q2 2026 in Review

Larson Financial Group increased its Phibro Animal Health (PAHC) stake by 82% in Q2 2026, buying an estimated $2.36K and bringing the position to 124 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2870.

Larson Financial Group first reported a position in PAHC in Q2 2025 and has held it in 5 quarters since. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Larson Financial Group held 124 shares of Phibro Animal Health worth $3.89K as of Q2 2026.
  • Larson Financial Group bought 56 Phibro Animal Health shares in Q2 2026, an estimated $2.36K.
  • Phibro Animal Health made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2870 holding.
  • Larson Financial Group first reported a position in Phibro Animal Health in Q2 2025 and has held it in 5 quarters since.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.